Business Context and Reporting Period
This Form 8-K Current Report was filed by ClearPoint Neuro, Inc. (formerly MRI Interventions, Inc.) on February 12, 2020, regarding events occurring on February 11 and 12, 2020. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Corporate Name Change: Effective February 12, 2020, the Company changed its name from "MRI Interventions, Inc." to "ClearPoint Neuro, Inc."
- Bylaws Amendment: The Board of Directors adopted Second Amended and Restated Bylaws to reflect the name change.
- Trading Symbol Update: Effective February 12, 2020, the Company's common stock began trading under the new ticker symbol "CLPT" (previously MRI).
- CUSIP Update: The new CUSIP number for the common stock is 18507C 10 3.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. The document strictly addresses the administrative execution of the name and ticker symbol change.
Investor Verification Checklist
- Verify the new ticker symbol "CLPT" on trading platforms effective February 12, 2020.
- Confirm the new CUSIP number (18507C 10 3) for record-keeping and settlement purposes.
- Review the Certificate of Amendment (Exhibit 3.1) and Second Amended and Restated Bylaws (Exhibit 3.2) for full legal details of the name change.
- Note that the press release referenced in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act.